Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.
Department of Cardiology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CIBERCV, Madrid, Spain.
ESC Heart Fail. 2021 Jun;8(3):2306-2309. doi: 10.1002/ehf2.13256. Epub 2021 Mar 2.
The concept that cell-based repair of myocardial injury might be possible was introduced almost two decades ago; however, the field of cardiovascular reparative medicine has been criticized as translation to clinically effective approaches has been slow. The recent retraction of a series of papers has further impacted perception of this area of research. As researchers, clinicians, and teachers in this field, we felt it incumbent to critically appraise the current state of cardiac cell repair, determine what can be learned from past mistakes, and formulate best practices for future work. This special communication summarizes an introspective assessment of what has fallen short, how to prevent similar issues, and how the field might best move forward in the service of science and patients.
近二十年前,人们提出了利用细胞修复心肌损伤的理念;然而,心血管修复医学领域一直备受争议,因为向临床有效方法的转化进展缓慢。最近撤回了一系列论文,这进一步影响了人们对该研究领域的看法。作为该领域的研究人员、临床医生和教师,我们觉得有必要批判性地评估心脏细胞修复的现状,从过去的错误中吸取教训,并为未来的工作制定最佳实践。本专题通讯总结了对不足之处的反思评估、如何防止类似问题,以及该领域如何在为科学和患者服务的前提下最好地向前发展。